계명대학교 의학도서관 Repository

Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer

Metadata Downloads
Author(s)
Boram ChoiHyuk-Joon LeeJimin MinHwi-Nyeong ChoeYun-Suk ChoiYoung-Gil SonHye-Seong AhnYun-Suhk SuhJames R. GoldenringeHan-Kwang Yang
Keimyung Author(s)
Son, Young Gil
Department
Dept. of Surgery (외과학)
Journal Title
Cancer Biomarkers
Issued Date
2017
Volume
19
Issue
3
Keyword
CDH17ELISATFF3gastric cancer marker
Abstract
BACKGROUND:

Few reliable blood markers are available for detecting gastric cancer, mainly owing to the heterogeneity of the cancer.

OBJECTIVE:

To establish gastric cancer diagnostic markers, we evaluated the levels of plasma cadherin 17 (CDH17) and trefoil factor 3 (TFF3), which are secretory proteins and known markers for intestinal metaplasia (IM), in patients with gastric cancer.

METHOD:

The protein expression level was analyzed in blood plasma samples from 111 gastric cancer patients and 44 healthy individuals, using a sandwich ELISA kit, followed by statistical analyses.

RESULT:

Overall, the plasma levels of CDH17 and TFF3 were not significantly different between groups (p= 0.160 and p= 0.113, respectively). However, CDH17 expression was significantly elevated in patients with stage II and III gastric cancers compared to that in healthy controls (p= 0.023 and p= 0.037, respectively). In contrast, TFF3 levels were significantly elevated in patients with stage I (p= 0.001) and T1 gastric cancer (p= 0.013). The sensitivity and specificity of CDH17 were 66.7 and 61.4%, respectively (cutoff point: 0.189 ng/mL); for TFF3, these values were 62.2 and 56.8%, respectively (cutoff point: 5.215 ng/mL).

CONCLUSIONS:

These findings indicate that secretory protein markers for metaplastic lineages can be used as blood markers for gastric cancer.
Keimyung Author(s)(Kor)
손영길
Publisher
School of Medicine (의과대학)
Citation
Boram Choi et al. (2017). Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer. Cancer Biomarkers, 19(3), 231–239. doi: 10.3233/CBM-160147
Type
Article
ISSN
1574-0153
Source
https://content.iospress.com/articles/cancer-biomarkers/cbm160147
DOI
10.3233/CBM-160147
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/41388
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Surgery (외과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.